These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16600701)

  • 21. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry.
    Ewald AH; Peters FT; Weise M; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):123-31. PubMed ID: 16027051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Ehlers D; Maurer HH
    Anal Bioanal Chem; 2008 Apr; 390(7):1837-42. PubMed ID: 18259731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
    Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
    J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo metabolism of 2,5-dimethoxy-4-propylthiophenethylamine in rat.
    Kanamori T; Kuwayama K; Tsujikawa K; Miyaguchi H; Iwata YT; Inoue H; Kishi T
    Xenobiotica; 2007 Jun; 37(6):679-92. PubMed ID: 17614010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection.
    Tsai CC; Liu JT; Shu YR; Chan PH; Lin CH
    J Chromatogr A; 2006 Jan; 1101(1-2):319-23. PubMed ID: 16325192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of four thiophenethylamine designer drugs (2C-T-4, 2C-T-8, 2C-T-13, 2C-T-17) in human urine by capillary electrophoresis/mass spectrometry.
    Nieddu M; Boatto G; Pirisi MA; Dessì G
    Rapid Commun Mass Spectrom; 2010 Aug; 24(16):2357-62. PubMed ID: 20635321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
    Meyer MR; Wilhelm J; Peters FT; Maurer HH
    Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
    Habrdova V; Peters FT; Theobald DS; Maurer HH
    J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations using GC-MS, LC-MS(n), and LC-high resolution-MS/MS.
    Wink CS; Meyer GM; Zapp J; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(6):1545-57. PubMed ID: 25577353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.
    Kerrigan S; Mott A; Jatzlau B; Ortiz F; Perrella L; Martin S; Bryand K
    J Forensic Sci; 2014 Jan; 59(1):175-83. PubMed ID: 24313279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
    Kraemer T; Bickeboeller-Friedrich J; Maurer HH
    Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series).
    Theobald DS; Maurer HH
    Biochem Pharmacol; 2007 Jan; 73(2):287-97. PubMed ID: 17067556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
    Staack RF; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):333-42. PubMed ID: 14643514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and identification of urinary metabolites of 4-iodo-2,5-dimethoxyphenethylamine.
    Kanamori T; Kuwayama K; Tsujikawa K; Miyaguchi H; Iwata YT; Inoue H
    J Forensic Sci; 2011 Sep; 56(5):1319-23. PubMed ID: 21595694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS.
    Meyer MR; Prosser D; Maurer HH
    Drug Test Anal; 2013 Apr; 5(4):259-65. PubMed ID: 23303532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
    Staack RF; Maurer HH
    J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.